450 results on '"Gilbertson, Michael"'
Search Results
52. Real-World Outcomes of Patients with Primary CNS Lymphoma (PCNSL): A Report from the Australasian Lymphoma Alliance (ALA)
53. High-Dose Methotrexate Is Not Associated with Reduction in CNS Relapse in Patients with Aggressive B-Cell Lymphoma: An International Retrospective Study of 2300 High-Risk Patients
54. Real-World Outcomes of Aggressive B-Cell Non-Hodgkin Lymphoma in People Living with HIV (PLWH) Treated in Australia: An Australasian Lymphoma Alliance Study
55. Promising Real World Survival Data in Adult-Onset Langerhans Cell Histiocytosis: An Australasian Lymphoma Alliance 20 Year Retrospective Study
56. Abnormal Chicks and PCB Residue Levels in Eggs of Colonial Birds on the Lower Great Lakes (1971-73)
57. God and History in the Book of Revelation: New Testament Studies in Dialogue with Pannenberg and Moltmann
58. Salvage radiotherapy associates with durable response for a subset of patients with limited stage refractory DLBCL
59. Safety of rapid injection of undiluted ferric carboxymaltose to patients with iron‐deficiency anaemia: a Phase II single‐arm study
60. Tislelizumab, an Anti-PD1 Antibody, in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma in Tirhol Bgb-A317-210: A Prospective Multicenter Lysa Phase 2 Study Conducted in Western Countries
61. Optimizing Immunoglobulin Replacement Therapy for Patients with B-Cell Malignancies and Hypogammaglobulinemia: The Investigator-Initiated, International, Randomized Phase II/III Rational Platform Trial, and the Rationalise (STOP IgRT) Domain
62. Disseminated enteroviral infection associated with obinutuzumab
63. WELCOME HOME: How our school district supports English learners.
64. A Description of the Type, Frequency and Severity of Infections Among Sixteen Patients Treated for T-Cell Lymphoma
65. Immune priming with nivolumab followed by nivolumab and rituximab in first-line treatment of follicular lymphoma: The phase 2 1st FLOR study.
66. Infusional dose-adjusted epoch plus bortezomib for the treatment of plasmablastic lymphoma
67. 5. Farm Work in Ontario and Breast Cancer Risk
68. Investigations of heavy metals in Common Tern populations
69. Pollutants in breeding Herring Gulls in the lower Great Lakes
70. Regulating Chemical Accumulation in the Environment: The Integration of Toxicology and Economics in Environmental Policymaking.
71. Testing the low dose mixtures hypothesis from the Halifax project
72. Excellent outcomes of transformed lymphomas in the rituximab era without autologous stem cell transplantation: an Australian, single‐centre experience
73. Introduction: Methodology for Assessing Community Health in Areas of Concern: Measuring the Adverse Effects on Human Health
74. Occupation and Breast Cancer: A Canadian Case–Control Study
75. Scientific Issues in Relation to Lakewide Management Plans: Linking Science and Policy
76. An ecosystem approach to the health effects of mercury in the Great Lakes basin ecosystem
77. Male cerebral palsy hospitalization as a potential indicator of neurological effects of methylmercury exposure in Great Lakes communities
78. Excellent outcomes of transformed lymphomas in the rituximab era without autologous stem cell transplantation: an Australian single-centre experience.
79. Restoring the Great Lakes - Means and ends
80. Characteristics of the breeding failure of a colony of Herring Gulls on Lake Ontario
81. Early embryonic mortality in a Herring Gull colony in Lake Ontario
82. Freshwater avain and mammalian predators as indicators of aquatic environmental quality
83. Canadian Wildlife Serviceʼs Herring Gull Monitoring Program: Importance to the development of environmental policy on organohalogens
84. Breast cancer risk in relation to occupations with exposure to carcinogens and endocrine disruptors: a Canadian case–control study
85. Immune Priming with Single-Agent Nivolumab Followed By Combined Nivolumab & Rituximab Is Safe and Efficacious for First-Line Treatment of Follicular Lymphoma; Interim Analysis of the '1st FLOR' Study
86. A multicenter retrospective comparison of induction chemoimmunotherapy regimens on outcomes in transplant‐eligible patients with previously untreated mantle cell lymphoma
87. Lead poisoning from bench to bed-side
88. Preface
89. Organochlorine Contaminants in the Great Lakes
90. CEPA under attack: Canada (Attorney General) v. Hydro-Quebec.
91. Outcomes of Stage I and II Follicular Lymphoma in the Era of 18F-FDG PET-CT Staging: An International Collaborative Study from the Australian Lymphoma Alliance
92. Causality Advocacy: Workers’ Compensation Cases as Resources for Identifying and Preventing Diseases of Modernity
93. Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphoma
94. Failure to achieve early disease response is associated with inferior survival in patients with newly diagnosed multiple myeloma
95. Infection is an Independent Predictor of Death in Diffuse Large B Cell Lymphoma
96. Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphoma.
97. Causality Advocacy: Workers' Compensation Cases as Resources for Identifying and Preventing Diseases of Modernity.
98. HORMONAL CHAOS: THE SCIENTIFIC AND SOCIAL ORIGINS OF THE ENVIRONMENTAL ENDOCRINE HYPOTHESIS
99. Routine Blood Investigations Have Limited Utility in Routine Surveillance of High-Grade Lymphomas (HGL) in Remission after First-Line Therapy
100. An International Collaborative Study of Outcome and Prognostic Factors in Patients with Secondary CNS Involvement By Diffuse Large B-Cell Lymphoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.